Telegram RegisterThe public register of Telegram
Telegram profile photo for Рак Желудка и Пищевода. Информационный Канал. Всероссийское сообщество пациентов. Onco Help

Channel

Рак Желудка и Пищевода. Информационный Канал. Всероссийское сообщество пациентов. Onco Help

@stomachcanceroncohelp

On this record: Topic · Growth · Engagement · Reactions · Posts · Citations · Telegram's recommendations · Cite this entry

1,091subscribers

+42 since we began measuring on 6 August 2026

Risers and fallers across the register · movement among entries of 1,000–3,162.

Register entry

Telegram ID-1001834115302
TypeChannel
Username@stomachcanceroncohelp
CreatedBetween 1 October 2022 and 30 September 2023 — estimated from Telegram’s id allocation, not measured. How this range is calculated.
First recorded6 August 2026
Last confirmed live17 September 2026
Measurements held15
Confirmed unchanged1 time, most recently 17 September 2026
On Telegramt.me/stomachcanceroncohelp

Topic

Health & wellness — a classification, not a measurement. An on-box language model (Qwen3.6-35B-A3B-FP8, prompt version 1) read this channel’s own recent posts on 19 September 2026 and assigned it the closest of 31 fixed categories, at 99% confidence. This is a model’s judgement about what the channel is likely to be about, not a fact this register measured the way a subscriber count or a view count is measured — it can be revised on a later pass, and it carries no weight anywhere else on this page. How this classification works, and why it has no browse page of its own yet.

Growth

1,0491,0931,0716 August 2026 — 1,049 subscribers6 August 2026 — 1,049 subscribers6 August 2026 — 1,051 subscribers9 August 2026 — 1,054 subscribers12 August 2026 — 1,060 subscribers15 August 2026 — 1,062 subscribers18 August 2026 — 1,064 subscribers22 August 2026 — 1,066 subscribers25 August 2026 — 1,069 subscribers28 August 2026 — 1,073 subscribers31 August 2026 — 1,084 subscribers4 September 2026 — 1,088 subscribers9 September 2026 — 1,093 subscribers13 September 2026 — 1,090 subscribers17 September 2026 — 1,091 subscribers1,0916 August 202617 September 2026
15 measurements spanning 42 days, net +42. Dots are measurements; the straight line between them is drawn to join them, not to claim we know the path taken in between — snapshots are recorded only when a count changes, so gaps mean “no change observed”, never “interpolated”. The vertical axis spans 1,042–1,100 and does not start at zero.
Measurement log — every subscribers count we have recorded
Measured (UTC)SubscribersChange
17 Sept 2026, 01:191,091+1
13 Sept 2026, 08:391,090-3
9 Sept 2026, 03:591,093+5
4 Sept 2026, 05:161,088+4
31 Aug 2026, 12:531,084+11
28 Aug 2026, 03:081,073+4
25 Aug 2026, 07:031,069+3
22 Aug 2026, 01:371,066+2
18 Aug 2026, 17:551,064+2
15 Aug 2026, 19:541,062+2
12 Aug 2026, 15:541,060+6
9 Aug 2026, 05:511,054+3
6 Aug 2026, 15:111,051+2
6 Aug 2026, 12:511,049no change
6 Aug 2026, 08:151,049first reading

Engagement

6 posts held, back to 3 July 2026the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 page of Telegram’s post history, 20 posts per page.

Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 6 posts for this entry, the most recent from 4 August 2026. An engagement rate over an empty window would be a number about nothing.

Reaction mix

31 reactions across 6 posts, in 4 distinct kinds. The most used accounts for 48.4% of them.

Every reaction kind recorded on the sample, most used first
ReactionCountShareShare, drawn
👍1548.4%
1238.7%
🙏39.68%
🔥13.23%

No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.

Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.

Coverage. Reactions were read on 6 of the 6 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 31 reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.

Measured over the 6 most recent posts we hold, published 3 July 2026 to 4 August 2026, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.

Recent posts

4 Aug 2026, 10:59 UTC93 views5 reactionsread 6 August 2026
Forwarded from @schoolofchemotherapy

Итак, бициклол, адеметионин и ремаксол Начнем с того, что все указанные выше гепатопротекторы включены в клин реки RUSSCO по поддерживающей терапии. Однако, как и многое в сопроводительной терапии в онкологии, уровни доказательности этих препаратов не сильно то и высоки. Но, стоп... этот пост я пишу не с целью того, чтобы эти препараты не назначались для лечения гепатотоксичности и тд. Про лечение лекарственного пор

👍5

Signed Алена Рыбакова

29 Jul 2026, 05:13 UTC227 views6 reactionsread 6 August 2026
Forwarded from @oncology_news_2022Photo

Рак желудка: сонеситатуг ведотин улучшает общую выживаемость пациентов во 2+ линии терапии CLDN18.2+ опухолей AstraZeneca анонсировала позитивные результаты исследования III фазы CLARITY-Gastric01 - оценка эффективности нового ADC к клаудину 18.2. В соответствии с пресс-релизом - отмечено достоверное увеличение общей выживаемости пациентов, получавших сонеситатуг ведотин (Sone-Ve) в сравнении с контрольной группой в

🙏32🔥1

Signed Алена Рыбакова

13 Jul 2026, 09:00 UTC369 views13 reactionsread 6 August 2026
Forwarded from @oncolikbezPhoto

Что нового в контроле над периферической полинейропатией, вызванной химиотерапией (ХИПН)? Более подробно о том, что писала тут. Из доклада д.м.н. А.В.Снегового на "Белых ночах". Итак, в профилактике ХИПН себя многообещающе показал лозартан в дозировке 100 мг в сутки. В открытое КИ было включено 89 пациентов, группа сравнения велась стандартно, а протокола профилактики ХИПН пока нет. В результате группа на лозартане

👍103

Signed Алена Рыбакова

4 Jul 2026, 11:55 UTC444 views3 reactionsread 6 August 2026
Forwarded from @oncology_news_2022Photo

При аденокарциноме желудка используются сразу несколько иммуногистохимических тестов PD-L1 и несколько систем оценки экспрессии, но доказательств их реальной взаимозаменяемости было немного. Для одного и того же пациента разные тест-системы теоретически могут давать разный результат. Исследование EORTC ASPIRE поставило перед собой задачу проверить, можно ли на практике использовать эти тесты и системы подсчёта взаимо

3

Signed Алена Рыбакова

4 Jul 2026, 11:50 UTC320 views2 reactionsread 6 August 2026
Forwarded from @oncology_news_2022Photo

В основном анализе HERIZON-GEA-01 занидатамаб уже показал статистически значимое улучшение ВБП и ОВ для комбинации с тислелизумабом и ХТ против трастузумаба с ХТ в первой линии HER2-позитивного рака желудка. Представлен поданализ по глубине ответа в данной работе - DpR - максимальное процентное уменьшение суммы диаметров опухолевых очагов от исходного. И ВБП2 - время от рандомизации до прогрессирования уже на послед

2

Signed Алена Рыбакова

3 Jul 2026, 16:01 UTC265 views2 reactionsread 6 August 2026
Forwarded from @oncology_news_2022Photo

В первом промежуточном анализе исследования 3 фазы HERIZON-GEA-01 занидатамаб (zani - биспецифический паратопик к Her-2) в комбинации с ХТ ± тислелизумабом (TIS - анти-PD-L1антитело) уже показал значимое улучшение ВБП (продление медианы более чем на 4 месяца) и, с добавлением иммунотерапии, значимый выигрыш по ОВ (более 7 месяцев) против трастузумаба с ХТ в первой линии HER2-позитивного метастатического рака желудка.

2

Signed Алена Рыбакова

Showing the 6 most recent of 6 posts we hold for @stomachcanceroncohelp. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.

Forward network

Republished by

Channels on the register that have forwarded this channel's posts into their own feed.

Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.

Mentions

Names

Channels on the register whose handles appear in this channel's posts.

A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.

Appears in Telegram’s recommendations for other channels

The reverse of the list above, and a different kind of signal. This does not require this channel to have ever been asked about directly — each row below is a channel we DID ask Telegram about, whose Telegram-generated list happened to include this one. A channel can appear here with an empty list above it, because being named by someone else’s query is independent of having been queried itself.

Инна Тулина хирург онколог, кмн
@inna_tulina_a · 30,140
Telegram ranks this channel #44 of 94 here — alongside 93 others — read 7 September 2026

This channel appears in 1 seed channel's Telegram-generated recommendation list in total. Each is Telegram’s list for THAT channel, not this one — see how this is measured.

Cite this entry

A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 17 September 2026 — this entry's latest reading, not the date you are reading this.

“Рак Желудка и Пищевода. Информационный Канал. Всероссийское сообщество пациентов. Onco Help” (@stomachcanceroncohelp), 1,091 subscribers as measured 17 September 2026. Telegram Register, tgregister.com/channel/stomachcanceroncohelp.

Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.